KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Capital Expenditures (2018 - 2025)

Vir Biotechnology's Capital Expenditures history spans 8 years, with the latest figure at $348000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 82.56% to $348000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $4.8 million, a 33.82% decrease, with the full-year FY2025 number at $4.8 million, down 33.82% from a year prior.
  • Capital Expenditures hit $348000.0 in Q4 2025 for Vir Biotechnology, up from $317000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for VIR hit a ceiling of $20.6 million in Q2 2022 and a floor of $317000.0 in Q3 2025.
  • Historically, Capital Expenditures has averaged $6.2 million across 5 years, with a median of $2.5 million in 2021.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 4090.74% in 2022 and later crashed 92.96% in 2024.
  • Tracing VIR's Capital Expenditures over 5 years: stood at $17.6 million in 2021, then decreased by 28.66% to $12.6 million in 2022, then plummeted by 87.79% to $1.5 million in 2023, then grew by 29.97% to $2.0 million in 2024, then tumbled by 82.56% to $348000.0 in 2025.
  • Business Quant data shows Capital Expenditures for VIR at $348000.0 in Q4 2025, $317000.0 in Q3 2025, and $2.5 million in Q2 2025.